Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers
- 1 August 2004
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 66 (2) , 312-321
- https://doi.org/10.1124/mol.104.000398
Abstract
Heterodimerization has been documented for several members of the G protein-coupled receptor (GPCR) superfamily, including the closely related MT(1) and MT(2) melatonin receptors. However, the relative abundance of hetero-versus homodimers and the specific properties, which can be attributed to each form, are difficult to determine. Using a bioluminescence resonance energy transfer (BRET) donor saturation assay, we show that half-maximal MT(1)/MT(2) heterodimer formation is reached for expression levels as low as approximately 4000 receptors per cell. The relative propensity of MT(1) homodimer and MT(1)/MT(2) heterodimer formation are similar, whereas that for the MT(2) homodimer formation is 3- to 4-fold lower. These data indicate that both the relative expression level of each receptor isoform and the affinities between monomers may determine the actual proportion of homo- and heterodimers. The specific interaction of ligands with the MT(1)/MT(2) heterodimer was studied using a BRET-based assay as a readout for the conformational changes of the heterodimer. An MT(1)/MT(2) heterodimer-specific profile and ligands selective for the MT(1)/MT(2) heterodimer compared with the MT(2) homodimer could be identified. Classic radioligand binding and BRET studies suggest that heterodimers contain two functional ligand binding sites that maintain their respective selectivity for MT(1) and MT(2) ligands. Occupation of either binding site is sufficient to induce a conformational change within the heterodimer. Taken together, these results show that the probability of GPCR heterodimer formation may be equal to or even higher than that of the corresponding homodimers and that specific properties of heterodimers can be revealed using a BRET-based ligand/receptor interaction assay.Keywords
This publication has 41 references indexed in Scilit:
- Activation of the Leptin Receptor by a Ligand-induced Conformational Change of Constitutive Receptor DimersPublished by Elsevier ,2003
- New selective ligands of human cloned melatonin MT1 and MT2 receptorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2003
- Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy TransferJournal of Biological Chemistry, 2002
- Functional Expression of MT2 (Mel1b) Melatonin Receptors in Human PAZ6 AdipocytesEndocrinology, 2001
- Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)Proceedings of the National Academy of Sciences, 2000
- Dual Signaling of Human Mel1a Melatonin Receptors via Gi2, Gi3, and Gq/11 ProteinsMolecular Endocrinology, 1999
- Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptorNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1997
- Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of RhodopsinScience, 1996
- Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina.Proceedings of the National Academy of Sciences, 1987
- Melatonin is a potent modulator of dopamine release in the retinaNature, 1983